JPWO2020123938A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020123938A5 JPWO2020123938A5 JP2021533530A JP2021533530A JPWO2020123938A5 JP WO2020123938 A5 JPWO2020123938 A5 JP WO2020123938A5 JP 2021533530 A JP2021533530 A JP 2021533530A JP 2021533530 A JP2021533530 A JP 2021533530A JP WO2020123938 A5 JPWO2020123938 A5 JP WO2020123938A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- polypeptide
- item
- antigen
- items
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 451
- 229920001184 polypeptide Polymers 0.000 claims description 443
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 443
- 108091007433 antigens Proteins 0.000 claims description 182
- 239000000427 antigen Substances 0.000 claims description 180
- 102000036639 antigens Human genes 0.000 claims description 180
- 239000012634 fragment Substances 0.000 claims description 157
- 210000004027 cell Anatomy 0.000 claims description 128
- -1 CD86 Proteins 0.000 claims description 81
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims description 63
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 61
- 230000011664 signaling Effects 0.000 claims description 57
- 108010027179 Tacrolimus Binding Proteins Proteins 0.000 claims description 50
- 102000018679 Tacrolimus Binding Proteins Human genes 0.000 claims description 50
- 230000000139 costimulatory effect Effects 0.000 claims description 46
- 239000003446 ligand Substances 0.000 claims description 42
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 41
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 41
- 108010003723 Single-Domain Antibodies Proteins 0.000 claims description 36
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims description 34
- 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims description 34
- 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 34
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 33
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 33
- 108091008874 T cell receptors Proteins 0.000 claims description 33
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 33
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 31
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 31
- 206010028980 Neoplasm Diseases 0.000 claims description 31
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 31
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 31
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims description 30
- 108090000623 proteins and genes Proteins 0.000 claims description 29
- 102000004169 proteins and genes Human genes 0.000 claims description 29
- 101000679851 Homo sapiens Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 27
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims description 26
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims description 26
- 102100038078 CD276 antigen Human genes 0.000 claims description 26
- 102100038083 Endosialin Human genes 0.000 claims description 26
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims description 26
- 229960002930 sirolimus Drugs 0.000 claims description 25
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 24
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 24
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 24
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 24
- 101000884275 Homo sapiens Endosialin Proteins 0.000 claims description 24
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 24
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 24
- 101710185679 CD276 antigen Proteins 0.000 claims description 23
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims description 21
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 21
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 21
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 21
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims description 21
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 21
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 21
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 21
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 21
- 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 claims description 19
- 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 claims description 19
- 102100027207 CD27 antigen Human genes 0.000 claims description 18
- 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 18
- 102000001301 EGF receptor Human genes 0.000 claims description 17
- 108060006698 EGF receptor Proteins 0.000 claims description 17
- 101000836765 Homo sapiens Protein amnionless Proteins 0.000 claims description 17
- 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 claims description 17
- 102100027097 Protein amnionless Human genes 0.000 claims description 17
- 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 claims description 17
- 239000003431 cross linking reagent Substances 0.000 claims description 17
- 101000920667 Homo sapiens Epithelial cell adhesion molecule Proteins 0.000 claims description 16
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims description 14
- 101710188619 C-type lectin domain family 12 member A Proteins 0.000 claims description 14
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims description 14
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims description 14
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims description 14
- 102100024965 Caspase recruitment domain-containing protein 11 Human genes 0.000 claims description 14
- 102100028757 Chondroitin sulfate proteoglycan 4 Human genes 0.000 claims description 14
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims description 14
- 101710116743 Ephrin type-A receptor 2 Proteins 0.000 claims description 14
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims description 14
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 14
- 102100029360 Hematopoietic cell signal transducer Human genes 0.000 claims description 14
- 101000761179 Homo sapiens Caspase recruitment domain-containing protein 11 Proteins 0.000 claims description 14
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 14
- 101001010823 Homo sapiens Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 claims description 14
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 claims description 14
- 102100024032 Linker for activation of T-cells family member 1 Human genes 0.000 claims description 14
- 102100034709 Lymphocyte cytosolic protein 2 Human genes 0.000 claims description 14
- 102100037020 Melanoma antigen preferentially expressed in tumors Human genes 0.000 claims description 14
- 101710178381 Melanoma antigen preferentially expressed in tumors Proteins 0.000 claims description 14
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims description 14
- 102100026181 Placenta-specific protein 1 Human genes 0.000 claims description 14
- 108050005093 Placenta-specific protein 1 Proteins 0.000 claims description 14
- 101710120463 Prostate stem cell antigen Proteins 0.000 claims description 14
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims description 14
- 102100037686 Protein SSX2 Human genes 0.000 claims description 14
- 102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 claims description 14
- 102100029198 SLAM family member 7 Human genes 0.000 claims description 14
- 102100029453 T-cell receptor-associated transmembrane adapter 1 Human genes 0.000 claims description 14
- 108010060889 Toll-like receptor 1 Proteins 0.000 claims description 14
- 208000008383 Wilms tumor Diseases 0.000 claims description 14
- 208000026448 Wilms tumor 1 Diseases 0.000 claims description 14
- 102100022748 Wilms tumor protein Human genes 0.000 claims description 14
- 101710127857 Wilms tumor protein Proteins 0.000 claims description 14
- SRHNADOZAAWYLV-XLMUYGLTSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)O[C@H](CO)[C@H](O)[C@@H]1O SRHNADOZAAWYLV-XLMUYGLTSA-N 0.000 claims description 14
- 108010039524 chondroitin sulfate proteoglycan 4 Proteins 0.000 claims description 14
- 108090000229 Claudin-6 Proteins 0.000 claims description 13
- 102100031507 Fc receptor-like protein 5 Human genes 0.000 claims description 13
- 101710157460 Hematopoietic cell signal transducer Proteins 0.000 claims description 13
- 101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 claims description 13
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims description 13
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 13
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 13
- 102100033579 Trophoblast glycoprotein Human genes 0.000 claims description 13
- SSOORFWOBGFTHL-OTEJMHTDSA-N (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-oxopentanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SSOORFWOBGFTHL-OTEJMHTDSA-N 0.000 claims description 12
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 12
- 235000002198 Annona diversifolia Nutrition 0.000 claims description 12
- 102100032912 CD44 antigen Human genes 0.000 claims description 12
- 108010058905 CD44v6 antigen Proteins 0.000 claims description 12
- 102100025221 CD70 antigen Human genes 0.000 claims description 12
- 102100036466 Delta-like protein 3 Human genes 0.000 claims description 12
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 12
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 12
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims description 12
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims description 12
- 101000928513 Homo sapiens Delta-like protein 3 Proteins 0.000 claims description 12
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims description 12
- 101000991061 Homo sapiens MHC class I polypeptide-related sequence B Proteins 0.000 claims description 12
- 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims description 12
- 101001005725 Homo sapiens Melanoma-associated antigen 10 Proteins 0.000 claims description 12
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims description 12
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims description 12
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims description 12
- 101001064779 Homo sapiens Plexin domain-containing protein 2 Proteins 0.000 claims description 12
- 101000880770 Homo sapiens Protein SSX2 Proteins 0.000 claims description 12
- 101100101727 Homo sapiens RAET1L gene Proteins 0.000 claims description 12
- 101001132524 Homo sapiens Retinoic acid early transcript 1E Proteins 0.000 claims description 12
- 101001094545 Homo sapiens Retrotransposon-like protein 1 Proteins 0.000 claims description 12
- 101000607316 Homo sapiens UL-16 binding protein 5 Proteins 0.000 claims description 12
- 101000607320 Homo sapiens UL16-binding protein 2 Proteins 0.000 claims description 12
- 101000607318 Homo sapiens UL16-binding protein 3 Proteins 0.000 claims description 12
- 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 claims description 12
- 101710112634 Interleukin-13 receptor subunit alpha-2 Proteins 0.000 claims description 12
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 12
- 108010010995 MART-1 Antigen Proteins 0.000 claims description 12
- 102000016200 MART-1 Antigen Human genes 0.000 claims description 12
- 102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 claims description 12
- 102100030300 MHC class I polypeptide-related sequence B Human genes 0.000 claims description 12
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims description 12
- 102100025049 Melanoma-associated antigen 10 Human genes 0.000 claims description 12
- 102100034256 Mucin-1 Human genes 0.000 claims description 12
- 102100023123 Mucin-16 Human genes 0.000 claims description 12
- 102100029527 Natural cytotoxicity triggering receptor 3 ligand 1 Human genes 0.000 claims description 12
- 101710201161 Natural cytotoxicity triggering receptor 3 ligand 1 Proteins 0.000 claims description 12
- 102100031889 Plexin domain-containing protein 2 Human genes 0.000 claims description 12
- 102100040120 Prominin-1 Human genes 0.000 claims description 12
- 102100033964 Retinoic acid early transcript 1E Human genes 0.000 claims description 12
- 102100035721 Syndecan-1 Human genes 0.000 claims description 12
- 102100040010 UL-16 binding protein 5 Human genes 0.000 claims description 12
- 102100039989 UL16-binding protein 2 Human genes 0.000 claims description 12
- 102100040011 UL16-binding protein 3 Human genes 0.000 claims description 12
- 102100040013 UL16-binding protein 6 Human genes 0.000 claims description 12
- 241001416177 Vicugna pacos Species 0.000 claims description 12
- 239000000539 dimer Substances 0.000 claims description 12
- 102000006495 integrins Human genes 0.000 claims description 12
- 108010044426 integrins Proteins 0.000 claims description 12
- 239000010445 mica Substances 0.000 claims description 12
- 229910052618 mica group Inorganic materials 0.000 claims description 12
- 101150047061 tag-72 gene Proteins 0.000 claims description 12
- 239000013638 trimer Substances 0.000 claims description 12
- 102000005962 receptors Human genes 0.000 claims description 11
- 108020003175 receptors Proteins 0.000 claims description 11
- 101000818543 Homo sapiens Tyrosine-protein kinase ZAP-70 Proteins 0.000 claims description 10
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims description 10
- 102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 claims description 10
- 230000004913 activation Effects 0.000 claims description 10
- 230000015572 biosynthetic process Effects 0.000 claims description 10
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims description 10
- 101150013553 CD40 gene Proteins 0.000 claims description 9
- 102100032937 CD40 ligand Human genes 0.000 claims description 9
- 102100035793 CD83 antigen Human genes 0.000 claims description 9
- 102100037904 CD9 antigen Human genes 0.000 claims description 9
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 9
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims description 9
- 101000946856 Homo sapiens CD83 antigen Proteins 0.000 claims description 9
- 101000738354 Homo sapiens CD9 antigen Proteins 0.000 claims description 9
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 claims description 9
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 claims description 9
- 101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 claims description 9
- 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 claims description 9
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 9
- 101000634846 Homo sapiens T-cell receptor-associated transmembrane adapter 1 Proteins 0.000 claims description 9
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 9
- 101000763537 Homo sapiens Toll-like receptor 10 Proteins 0.000 claims description 9
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 claims description 9
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 claims description 9
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 claims description 9
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 claims description 9
- 101000669406 Homo sapiens Toll-like receptor 6 Proteins 0.000 claims description 9
- 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 claims description 9
- 101000800483 Homo sapiens Toll-like receptor 8 Proteins 0.000 claims description 9
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims description 9
- 101710195102 Lymphocyte cytosolic protein 2 Proteins 0.000 claims description 9
- 102100021462 Natural killer cells antigen CD94 Human genes 0.000 claims description 9
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 9
- 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 9
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims description 9
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 9
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 claims description 9
- 102100027009 Toll-like receptor 10 Human genes 0.000 claims description 9
- 102100024333 Toll-like receptor 2 Human genes 0.000 claims description 9
- 102100024324 Toll-like receptor 3 Human genes 0.000 claims description 9
- 102100039360 Toll-like receptor 4 Human genes 0.000 claims description 9
- 102100039357 Toll-like receptor 5 Human genes 0.000 claims description 9
- 102100039387 Toll-like receptor 6 Human genes 0.000 claims description 9
- 102100039390 Toll-like receptor 7 Human genes 0.000 claims description 9
- 102100033110 Toll-like receptor 8 Human genes 0.000 claims description 9
- 102100033117 Toll-like receptor 9 Human genes 0.000 claims description 9
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 9
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims description 8
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 claims description 8
- ZHYGVVKSAGDVDY-QQQXYHJWSA-N 7-o-demethyl cypher Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](O)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 ZHYGVVKSAGDVDY-QQQXYHJWSA-N 0.000 claims description 7
- BUROJSBIWGDYCN-GAUTUEMISA-N AP 23573 Chemical compound C1C[C@@H](OP(C)(C)=O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 BUROJSBIWGDYCN-GAUTUEMISA-N 0.000 claims description 7
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims description 7
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims description 7
- 229960005167 everolimus Drugs 0.000 claims description 7
- KASDHRXLYQOAKZ-ZPSXYTITSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-ZPSXYTITSA-N 0.000 claims description 7
- 229960005330 pimecrolimus Drugs 0.000 claims description 7
- 229960001302 ridaforolimus Drugs 0.000 claims description 7
- 229960001967 tacrolimus Drugs 0.000 claims description 7
- 229960000235 temsirolimus Drugs 0.000 claims description 7
- QFJCIRLUMZQUOT-UHFFFAOYSA-N temsirolimus Natural products C1CC(O)C(OC)CC1CC(C)C1OC(=O)C2CCCCN2C(=O)C(=O)C(O)(O2)C(C)CCC2CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C1 QFJCIRLUMZQUOT-UHFFFAOYSA-N 0.000 claims description 7
- YYSFXUWWPNHNAZ-PKJQJFMNSA-N umirolimus Chemical compound C1[C@@H](OC)[C@H](OCCOCC)CC[C@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 YYSFXUWWPNHNAZ-PKJQJFMNSA-N 0.000 claims description 7
- 229950007775 umirolimus Drugs 0.000 claims description 7
- CGTADGCBEXYWNE-JUKNQOCSSA-N zotarolimus Chemical compound N1([C@H]2CC[C@@H](C[C@@H](C)[C@H]3OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@@]4(O)[C@H](C)CC[C@H](O4)C[C@@H](/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C3)OC)C[C@H]2OC)C=NN=N1 CGTADGCBEXYWNE-JUKNQOCSSA-N 0.000 claims description 7
- 229950009819 zotarolimus Drugs 0.000 claims description 7
- 102000014914 Carrier Proteins Human genes 0.000 claims description 5
- 101001090688 Homo sapiens Lymphocyte cytosolic protein 2 Proteins 0.000 claims description 5
- 101710192730 Linker for activation of T-cells family member 1 Proteins 0.000 claims description 5
- 101710113863 T-cell receptor-associated transmembrane adapter 1 Proteins 0.000 claims description 5
- 108091008324 binding proteins Proteins 0.000 claims description 5
- 201000011510 cancer Diseases 0.000 claims description 5
- RJBDSRWGVYNDHL-XNJNKMBASA-N (2S,4R,5S,6S)-2-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2R,3S)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-amino-6-[(1S,2R)-2-[(2S,4R,5S,6S)-5-amino-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-4-hydroxyoxane-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H](O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@@H](CO)O[C@@]3(C[C@@H](O)[C@H](N)[C@H](O3)[C@H](O)[C@H](O)CO)C(O)=O)C(O)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@@H](O)\C=C\CCCCCCCCCCCCC RJBDSRWGVYNDHL-XNJNKMBASA-N 0.000 claims description 4
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims description 4
- 108090000015 Mesothelin Proteins 0.000 claims description 4
- 102000003735 Mesothelin Human genes 0.000 claims description 4
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 4
- 206010006187 Breast cancer Diseases 0.000 claims description 3
- 208000026310 Breast neoplasm Diseases 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 3
- 101000884279 Homo sapiens CD276 antigen Proteins 0.000 claims description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 3
- 102000043129 MHC class I family Human genes 0.000 claims description 3
- 108091054437 MHC class I family Proteins 0.000 claims description 3
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 3
- 201000005202 lung cancer Diseases 0.000 claims description 3
- 208000020816 lung neoplasm Diseases 0.000 claims description 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 3
- 201000001441 melanoma Diseases 0.000 claims description 3
- 201000002528 pancreatic cancer Diseases 0.000 claims description 3
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 3
- 102000012440 Acetylcholinesterase Human genes 0.000 claims description 2
- 108010022752 Acetylcholinesterase Proteins 0.000 claims description 2
- 208000023275 Autoimmune disease Diseases 0.000 claims description 2
- 206010005003 Bladder cancer Diseases 0.000 claims description 2
- 206010005949 Bone cancer Diseases 0.000 claims description 2
- 208000018084 Bone neoplasm Diseases 0.000 claims description 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims description 2
- 101710120600 Cancer/testis antigen 1 Proteins 0.000 claims description 2
- 102100039510 Cancer/testis antigen 2 Human genes 0.000 claims description 2
- 101710120595 Cancer/testis antigen 2 Proteins 0.000 claims description 2
- 102000003846 Carbonic anhydrases Human genes 0.000 claims description 2
- 108090000209 Carbonic anhydrases Proteins 0.000 claims description 2
- 102100040835 Claudin-18 Human genes 0.000 claims description 2
- 108050009324 Claudin-18 Proteins 0.000 claims description 2
- 102300047802 Cutaneous T-cell lymphoma-associated antigen 1 isoform 1 Human genes 0.000 claims description 2
- 101710144543 Endosialin Proteins 0.000 claims description 2
- 101600098482 Homo sapiens Cutaneous T-cell lymphoma-associated antigen 1 (isoform 1) Proteins 0.000 claims description 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 2
- 206010025323 Lymphomas Diseases 0.000 claims description 2
- 208000034578 Multiple myelomas Diseases 0.000 claims description 2
- 206010033128 Ovarian cancer Diseases 0.000 claims description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
- 102100037891 Plexin domain-containing protein 1 Human genes 0.000 claims description 2
- 108050009432 Plexin domain-containing protein 1 Proteins 0.000 claims description 2
- 206010060862 Prostate cancer Diseases 0.000 claims description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
- 108010029485 Protein Isoforms Proteins 0.000 claims description 2
- 102000001708 Protein Isoforms Human genes 0.000 claims description 2
- 101710149284 Protein SSX2 Proteins 0.000 claims description 2
- 206010038389 Renal cancer Diseases 0.000 claims description 2
- 206010039491 Sarcoma Diseases 0.000 claims description 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims description 2
- 208000024313 Testicular Neoplasms Diseases 0.000 claims description 2
- 206010057644 Testis cancer Diseases 0.000 claims description 2
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 2
- 101150042088 UL16 gene Proteins 0.000 claims description 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 claims description 2
- 108010034265 Vascular Endothelial Growth Factor Receptors Proteins 0.000 claims description 2
- 229940022698 acetylcholinesterase Drugs 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 210000002950 fibroblast Anatomy 0.000 claims description 2
- 102000006815 folate receptor Human genes 0.000 claims description 2
- 108020005243 folate receptor Proteins 0.000 claims description 2
- 150000002270 gangliosides Chemical class 0.000 claims description 2
- 201000010536 head and neck cancer Diseases 0.000 claims description 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims description 2
- 201000005787 hematologic cancer Diseases 0.000 claims description 2
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims description 2
- 201000010982 kidney cancer Diseases 0.000 claims description 2
- 208000032839 leukemia Diseases 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 201000000849 skin cancer Diseases 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 201000003120 testicular cancer Diseases 0.000 claims description 2
- 201000002510 thyroid cancer Diseases 0.000 claims description 2
- 201000005112 urinary bladder cancer Diseases 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 102100038449 Claudin-6 Human genes 0.000 claims 2
- 102000010956 Glypican Human genes 0.000 claims 2
- 108050001154 Glypican Proteins 0.000 claims 2
- 108050007237 Glypican-3 Proteins 0.000 claims 2
- 102100027010 Toll-like receptor 1 Human genes 0.000 claims 2
- 101710190034 Trophoblast glycoprotein Proteins 0.000 claims 2
- 241000282832 Camelidae Species 0.000 claims 1
- 101000882898 Homo sapiens Claudin-6 Proteins 0.000 claims 1
- 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 claims 1
- 241000282842 Lama glama Species 0.000 claims 1
- 108010086911 MICB antigen Proteins 0.000 claims 1
- 108010006700 Receptor Tyrosine Kinase-like Orphan Receptors Proteins 0.000 claims 1
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims 1
- 230000004927 fusion Effects 0.000 description 106
- 239000013598 vector Substances 0.000 description 21
- 239000003795 chemical substances by application Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 14
- 238000003776 cleavage reaction Methods 0.000 description 13
- 230000007017 scission Effects 0.000 description 13
- 102100027205 B-cell antigen receptor complex-associated protein alpha chain Human genes 0.000 description 12
- 102100027203 B-cell antigen receptor complex-associated protein beta chain Human genes 0.000 description 12
- 102000003859 Claudin-6 Human genes 0.000 description 12
- 101000914489 Homo sapiens B-cell antigen receptor complex-associated protein alpha chain Proteins 0.000 description 12
- 101000914491 Homo sapiens B-cell antigen receptor complex-associated protein beta chain Proteins 0.000 description 12
- 102000001068 Neural Cell Adhesion Molecules Human genes 0.000 description 12
- 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 12
- 102000008229 Toll-like receptor 1 Human genes 0.000 description 12
- 244000303258 Annona diversifolia Species 0.000 description 11
- 102100032530 Glypican-3 Human genes 0.000 description 11
- 101001014668 Homo sapiens Glypican-3 Proteins 0.000 description 11
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 11
- 101000801433 Homo sapiens Trophoblast glycoprotein Proteins 0.000 description 11
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 11
- 238000004132 cross linking Methods 0.000 description 11
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 10
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 10
- 102000004631 Calcineurin Human genes 0.000 description 10
- 108010042955 Calcineurin Proteins 0.000 description 10
- 102000001493 Cyclophilins Human genes 0.000 description 10
- 108010068682 Cyclophilins Proteins 0.000 description 10
- 101000693708 Homo sapiens Sarcolipin Proteins 0.000 description 10
- 101000607306 Homo sapiens UL16-binding protein 1 Proteins 0.000 description 10
- 108020003285 Isocitrate lyase Proteins 0.000 description 10
- 102100025538 Sarcolipin Human genes 0.000 description 10
- 108010002687 Survivin Proteins 0.000 description 10
- 102100040012 UL16-binding protein 1 Human genes 0.000 description 10
- 229940127276 delta-like ligand 3 Drugs 0.000 description 10
- 102100025466 Carcinoembryonic antigen-related cell adhesion molecule 3 Human genes 0.000 description 8
- 229930105110 Cyclosporin A Natural products 0.000 description 8
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 8
- 108010036949 Cyclosporine Proteins 0.000 description 8
- 101000914337 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 3 Proteins 0.000 description 8
- 101000702132 Homo sapiens Protein spinster homolog 1 Proteins 0.000 description 8
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 8
- 108010022394 Threonine synthase Proteins 0.000 description 8
- 101001038499 Yarrowia lipolytica (strain CLIB 122 / E 150) Lysine acetyltransferase Proteins 0.000 description 8
- 102000004419 dihydrofolate reductase Human genes 0.000 description 8
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 8
- 229930191978 Gibberellin Natural products 0.000 description 5
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 5
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 5
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 5
- 239000003448 gibberellin Substances 0.000 description 5
- 229960000485 methotrexate Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 102000001253 Protein Kinase Human genes 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 108060006633 protein kinase Proteins 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229960001265 ciclosporin Drugs 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 3
- 229960001082 trimethoprim Drugs 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- 241000713704 Bovine immunodeficiency virus Species 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- 241000214054 Equine rhinitis A virus Species 0.000 description 2
- 241000713800 Feline immunodeficiency virus Species 0.000 description 2
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 2
- 241000713311 Simian immunodeficiency virus Species 0.000 description 2
- 241001648840 Thosea asigna virus Species 0.000 description 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 1
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000713756 Caprine arthritis encephalitis virus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000710188 Encephalomyocarditis virus Species 0.000 description 1
- 241000713730 Equine infectious anemia virus Species 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 206010066476 Haematological malignancy Diseases 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 102000016978 Orphan receptors Human genes 0.000 description 1
- 108070000031 Orphan receptors Proteins 0.000 description 1
- 240000007019 Oxalis corniculata Species 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 208000010094 Visna Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000037979 autoimmune inflammatory disease Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- 208000009724 equine infectious anemia Diseases 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 239000012642 immune effector Substances 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002993 trophoblast Anatomy 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024188998A JP2025010249A (ja) | 2018-12-14 | 2024-10-28 | 二量体形成剤調節性免疫受容体複合体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779971P | 2018-12-14 | 2018-12-14 | |
| US62/779,971 | 2018-12-14 | ||
| US201962835659P | 2019-04-18 | 2019-04-18 | |
| US62/835,659 | 2019-04-18 | ||
| PCT/US2019/066223 WO2020123938A1 (en) | 2018-12-14 | 2019-12-13 | Dimerizing agent regulated immunoreceptor complexes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024188998A Division JP2025010249A (ja) | 2018-12-14 | 2024-10-28 | 二量体形成剤調節性免疫受容体複合体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022513460A JP2022513460A (ja) | 2022-02-08 |
| JP2022513460A5 JP2022513460A5 (https=) | 2022-12-20 |
| JPWO2020123938A5 true JPWO2020123938A5 (https=) | 2022-12-20 |
| JP7636650B2 JP7636650B2 (ja) | 2025-02-27 |
Family
ID=71077012
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533530A Active JP7636650B2 (ja) | 2018-12-14 | 2019-12-13 | 二量体形成剤調節性免疫受容体複合体 |
| JP2024188998A Pending JP2025010249A (ja) | 2018-12-14 | 2024-10-28 | 二量体形成剤調節性免疫受容体複合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024188998A Pending JP2025010249A (ja) | 2018-12-14 | 2024-10-28 | 二量体形成剤調節性免疫受容体複合体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12516129B2 (https=) |
| EP (1) | EP3895052A4 (https=) |
| JP (2) | JP7636650B2 (https=) |
| KR (1) | KR20210104772A (https=) |
| CN (1) | CN113366479A (https=) |
| AU (1) | AU2019396553A1 (https=) |
| CA (1) | CA3123084A1 (https=) |
| IL (1) | IL283897A (https=) |
| WO (1) | WO2020123938A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018385699B2 (en) * | 2017-12-14 | 2024-08-15 | Regeneron Pharmaceuticals, Inc. | Daric interleukin receptors |
| US12291560B2 (en) | 2018-12-14 | 2025-05-06 | Regeneron Pharmaceuticals, Inc. | Dimerizing agent regulated immunoreceptor complexes |
| WO2020123938A1 (en) | 2018-12-14 | 2020-06-18 | Bluebird Bio, Inc. | Dimerizing agent regulated immunoreceptor complexes |
| KR20220004751A (ko) | 2019-05-04 | 2022-01-11 | 인히브릭스, 인크. | CLEC12a 결합 폴리펩타이드 및 이의 용도 |
| US12421315B2 (en) | 2019-05-08 | 2025-09-23 | Regeneron Pharmaceuticals, Inc. | CLL-1 targeted immunotherapies |
| WO2022099176A1 (en) * | 2020-11-09 | 2022-05-12 | 2Seventy Bio, Inc. | Aml targeted immunotherapies |
| EP4334361A1 (en) | 2021-05-05 | 2024-03-13 | Immatics Biotechnologies GmbH | Antigen binding proteins specifically binding prame |
| WO2022266075A1 (en) * | 2021-06-14 | 2022-12-22 | Caribou Biosciences, Inc. | Methods and materials for treating cancer using car constructs with an intracellular domain comprising a stap domain and a kinase domain or a stap domain and a phosphatase domain |
| CN113528455A (zh) * | 2021-07-19 | 2021-10-22 | 广州百暨基因科技有限公司 | 表达嵌合抗原受体的γδT细胞 |
| CN114736306B (zh) * | 2022-03-01 | 2024-04-19 | 中国科学院深圳先进技术研究院 | 一种受化学调控的蛋白酶工具及其配套底物 |
Family Cites Families (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US4873192A (en) | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
| US6534055B1 (en) | 1988-11-23 | 2003-03-18 | Genetics Institute, Inc. | Methods for selectively stimulating proliferation of T cells |
| US5858358A (en) | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
| US6905680B2 (en) | 1988-11-23 | 2005-06-14 | Genetics Institute, Inc. | Methods of treating HIV infected subjects |
| US6352694B1 (en) | 1994-06-03 | 2002-03-05 | Genetics Institute, Inc. | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells |
| US6291161B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertiore |
| US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| GB8918616D0 (en) | 1989-08-15 | 1989-09-27 | Univ Glasgow | Herpes simplex virus type 1 mutant |
| JP3257675B2 (ja) | 1990-10-12 | 2002-02-18 | マックス−プランク−ゲゼルシャフト ツール フェルデルング デル ビッセンシャフテン エー．ファウ． | 修飾リボザイム |
| HU215180B (hu) | 1992-01-23 | 1998-10-28 | Merck Patent Gmbh. | Eljárás monomer és dimer antitest-fragment fúziós fehérjék előállítására |
| US5652094A (en) | 1992-01-31 | 1997-07-29 | University Of Montreal | Nucleozymes |
| US5804413A (en) | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
| US6972193B1 (en) | 1993-02-12 | 2005-12-06 | Board Of Trustees Of Leland Stanford Junior University | Regulated transcription of targeted genes and other biological events |
| CZ206195A3 (en) | 1993-02-12 | 1996-04-17 | Univ Leland Stanford Junior | Controlled transcription of target genes and other biological materials |
| ES2229236T3 (es) | 1994-01-11 | 2005-04-16 | Dyax Corporation | Inhibidores de la plasmina humana derivados de los dominios de kunitz. |
| US7175843B2 (en) | 1994-06-03 | 2007-02-13 | Genetics Institute, Llc | Methods for selectively stimulating proliferation of T cells |
| GB9415319D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
| US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| US6692964B1 (en) | 1995-05-04 | 2004-02-17 | The United States Of America As Represented By The Secretary Of The Navy | Methods for transfecting T cells |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6187757B1 (en) | 1995-06-07 | 2001-02-13 | Ariad Pharmaceuticals, Inc. | Regulation of biological events using novel compounds |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| AU8605598A (en) | 1997-07-31 | 1999-02-22 | University Of Pittsburgh | Targeted hsv vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| CA2318402A1 (en) | 1998-01-15 | 1999-07-22 | Ariad Gene Therapeutics, Inc. | Regulation of biological events using multimeric chimeric proteins |
| AU766513B2 (en) | 1998-02-13 | 2003-10-16 | Board Of Trustees Of The Leland Stanford Junior University | Novel dimerizing agents, their production and use |
| AUPP221098A0 (en) | 1998-03-06 | 1998-04-02 | Diatech Pty Ltd | V-like domain binding molecules |
| FR2777909B1 (fr) | 1998-04-24 | 2002-08-02 | Pasteur Institut | Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex |
| CA2406864A1 (en) | 2000-02-24 | 2001-08-30 | Life Technologies Corporation | Simultaneous stimulation and concentration of cells |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| US6692736B2 (en) | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| NZ522840A (en) | 2000-06-01 | 2004-12-24 | Univ North Carolina | A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together |
| ATE452972T1 (de) | 2001-05-01 | 2010-01-15 | Ca Nat Research Council | Induzierbares expressionssystem in eukaryotischen zellen |
| WO2003057171A2 (en) | 2002-01-03 | 2003-07-17 | The Trustees Of The University Of Pennsylvania | Activation and expansion of t-cells using an engineered multivalent signaling platform |
| FR2872170B1 (fr) | 2004-06-25 | 2006-11-10 | Centre Nat Rech Scient Cnrse | Lentivirus non interactif et non replicatif, preparation et utilisations |
| EP1828390B1 (en) | 2004-12-15 | 2012-06-13 | The University Of North Carolina At Chapel Hill | Chimeric vectors |
| CN103555733A (zh) | 2005-01-05 | 2014-02-05 | F-星生物技术研究与开发有限公司 | 分子中互补决定区以外的区域中工程改造了的具有结合特性的合成免疫球蛋白结构域 |
| GB0504767D0 (en) | 2005-03-08 | 2005-04-13 | Ares Trading Sa | Lipocalin protein |
| EP1829895A1 (en) | 2006-03-03 | 2007-09-05 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
| WO2010062966A2 (en) | 2008-11-26 | 2010-06-03 | The General Hospital Corporation | Methods for inducing mixed chimerism |
| EP2396343B1 (en) | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| ES2683695T3 (es) | 2010-01-12 | 2018-09-27 | The University Of North Carolina At Chapel Hill | Repeticiones terminales invertidas restrictivas para vectores virales |
| CA2788682C (en) | 2010-02-05 | 2019-03-05 | The University Of North Carolina At Chapel Hill | Compositions and methods for enhanced parvovirus transduction |
| WO2011146862A1 (en) | 2010-05-21 | 2011-11-24 | Bellicum Pharmaceuticals, Inc. | Methods for inducing selective apoptosis |
| ES2791716T3 (es) | 2010-12-14 | 2020-11-05 | Univ Maryland | Células T que expresan al receptor de antígeno quimérico antietiqueta universal y métodos para el tratamiento del cáncer |
| EP3470431A1 (en) | 2012-09-27 | 2019-04-17 | Merus N.V. | Bispecific igg antibodies as t cell engagers |
| EP4303232A3 (en) | 2013-02-15 | 2024-04-17 | The Regents of The University of California | Chimeric antigen receptor and methods of use thereof |
| EP3447072A3 (en) | 2013-03-05 | 2019-05-22 | Baylor College of Medicine | Engager cells comprising cd3 scfv and an antigen recognition domain that binds a tumor antigen for immunotherapy |
| EP2964253A1 (en) | 2013-03-05 | 2016-01-13 | Baylor College Of Medicine | Heparanase expression in human t lymphocytes |
| WO2015017214A1 (en) | 2013-07-29 | 2015-02-05 | Bluebird Bio, Inc. | Multipartite signaling proteins and uses thereof |
| US10287354B2 (en) | 2013-12-20 | 2019-05-14 | Novartis Ag | Regulatable chimeric antigen receptor |
| US20170081411A1 (en) * | 2014-03-15 | 2017-03-23 | Novartis Ag | Regulatable chimeric antigen receptor |
| GB201405845D0 (en) | 2014-04-01 | 2014-05-14 | Ucl Business Plc | Signalling system |
| KR20170037625A (ko) | 2014-07-21 | 2017-04-04 | 노파르티스 아게 | Cll-1 키메라 항원 수용체를 사용한 암의 치료 |
| US11542488B2 (en) | 2014-07-21 | 2023-01-03 | Novartis Ag | Sortase synthesized chimeric antigen receptors |
| EP3288974B1 (en) | 2015-05-01 | 2020-11-04 | Inhibrx, Inc. | Type iii secretion system targeting molecules |
| EP3331913A1 (en) | 2015-08-07 | 2018-06-13 | Novartis AG | Treatment of cancer using chimeric cd3 receptor proteins |
| EP3341410B1 (en) | 2015-08-24 | 2021-06-02 | Cellectis | Chimeric antigen receptors with integrated controllable functions |
| WO2017125897A1 (en) | 2016-01-21 | 2017-07-27 | Novartis Ag | Multispecific molecules targeting cll-1 |
| MX2018010924A (es) | 2016-03-11 | 2019-02-13 | Bluebird Bio Inc | Células efectoras inmunitarias con edición genómica. |
| WO2017180993A1 (en) | 2016-04-14 | 2017-10-19 | Bluebird Bio, Inc. | Salvage chimeric antigen receptor systems |
| EP3494138A1 (en) | 2016-08-02 | 2019-06-12 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using fusion proteins |
| CN110352068A (zh) | 2016-12-02 | 2019-10-18 | 南加利福尼亚大学 | 合成的免疫受体及其使用方法 |
| WO2018127585A1 (en) * | 2017-01-06 | 2018-07-12 | Txcell | Monospecific regulatory t cell population with cytotoxicity for b cells |
| CN110582509A (zh) | 2017-01-31 | 2019-12-17 | 诺华股份有限公司 | 使用具有多特异性的嵌合t细胞受体蛋白治疗癌症 |
| AU2018385699B2 (en) | 2017-12-14 | 2024-08-15 | Regeneron Pharmaceuticals, Inc. | Daric interleukin receptors |
| MA51158A (fr) | 2017-12-14 | 2020-10-21 | Bluebird Bio Inc | Récepteurs daric nkg2d |
| JP7060084B2 (ja) | 2018-03-26 | 2022-04-26 | 三菱マテリアル株式会社 | 絶縁回路基板用接合体の製造方法および絶縁回路基板用接合体 |
| US12097219B2 (en) | 2018-09-10 | 2024-09-24 | Legend Biotech Ireland Limited | Single-domain antibodies against CLL1 and constructs thereof |
| CA3121478A1 (en) | 2018-11-30 | 2020-06-04 | Aleta Biotherapeutics Inc. | Single domain antibodies against cll-1 |
| AU2019397152A1 (en) | 2018-12-14 | 2021-06-24 | 2Seventy Bio, Inc. | Dimerizing agent regulated immunoreceptor complexes |
| WO2020123938A1 (en) | 2018-12-14 | 2020-06-18 | Bluebird Bio, Inc. | Dimerizing agent regulated immunoreceptor complexes |
| US20240034768A1 (en) | 2018-12-14 | 2024-02-01 | 2Seventy Bio, Inc. | Dimerizing agent regulated immunoreceptor complexes |
| US12291560B2 (en) | 2018-12-14 | 2025-05-06 | Regeneron Pharmaceuticals, Inc. | Dimerizing agent regulated immunoreceptor complexes |
| CA3126422A1 (en) | 2019-01-14 | 2020-07-23 | Nanjing Legend Biotech Co., Ltd. | Chimeric receptor polypeptides and uses thereof |
| EP3714941A1 (en) | 2019-03-27 | 2020-09-30 | Medigene Immunotherapies GmbH | Mage-a4 tcrs |
| KR20220004751A (ko) | 2019-05-04 | 2022-01-11 | 인히브릭스, 인크. | CLEC12a 결합 폴리펩타이드 및 이의 용도 |
| CA3139512A1 (en) | 2019-05-08 | 2020-11-12 | Inhibrx, Inc. | Cd123 targeted immunotherapies |
| US12421315B2 (en) | 2019-05-08 | 2025-09-23 | Regeneron Pharmaceuticals, Inc. | CLL-1 targeted immunotherapies |
| MX2022000896A (es) | 2019-07-24 | 2022-02-14 | Regeneron Pharma | Receptores de antigenos quimericos con especificidad por mage-a4 y usos de los mismos. |
| CA3154287A1 (en) | 2019-09-12 | 2021-03-18 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using fusion proteins |
| AU2020359530A1 (en) | 2019-09-30 | 2022-05-19 | 2Seventy Bio, Inc. | Dimerizing agent regulated immunoreceptor complexes |
| WO2021207613A1 (en) | 2020-04-10 | 2021-10-14 | 2Seventy Bio, Inc. | Frb antibodies |
-
2019
- 2019-12-13 WO PCT/US2019/066223 patent/WO2020123938A1/en not_active Ceased
- 2019-12-13 CA CA3123084A patent/CA3123084A1/en active Pending
- 2019-12-13 EP EP19896568.3A patent/EP3895052A4/en active Pending
- 2019-12-13 AU AU2019396553A patent/AU2019396553A1/en active Pending
- 2019-12-13 US US17/312,120 patent/US12516129B2/en active Active
- 2019-12-13 JP JP2021533530A patent/JP7636650B2/ja active Active
- 2019-12-13 CN CN201980091143.9A patent/CN113366479A/zh active Pending
- 2019-12-13 KR KR1020217021631A patent/KR20210104772A/ko not_active Ceased
-
2021
- 2021-06-10 IL IL283897A patent/IL283897A/en unknown
-
2024
- 2024-10-28 JP JP2024188998A patent/JP2025010249A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6633081B2 (ja) | 細胞 | |
| AU2021307614B2 (en) | Engineered immune cell for allotransplantation | |
| EP4219693A1 (en) | Chimeric antigen receptor targeting cd7 and use thereof | |
| JP6336684B2 (ja) | Ｐｄ−ｌ１によって誘導される免疫寛容の低減 | |
| JP2022116230A (ja) | 免疫療法用改変細胞 | |
| JP2019518425A5 (https=) | ||
| JP2020521759A (ja) | 免疫トレランスを調節するための多機能性の抗体−リガンド・トラップ | |
| FI3703750T3 (fi) | B-solujen maturaatioantigeenille spesifisiä kimeerisiä antigeenireseptoreita ja koodaavia polynukleotideja | |
| JP2021519580A5 (https=) | ||
| WO2017176525A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| JP2021532742A5 (https=) | ||
| KR20210135987A (ko) | Cd86 변이체 면역조절 단백질 및 그의 용도 | |
| JP2018537076A5 (https=) | ||
| EP4613781A1 (en) | Immune rejection-resistant engineered cell | |
| JP2023527194A (ja) | 腫瘍微小環境を逆転させる融合タンパク質及びその使用 | |
| CN115515983A (zh) | 人源化cd19抗体及其应用 | |
| KR20220143057A (ko) | Cd2 활성화를 갖는 키메라 항원 수용체 | |
| JPWO2020123938A5 (https=) | ||
| CN117004603A (zh) | 一种cd7基因被敲除的工程化免疫细胞及其用途 | |
| CN117187185A (zh) | 一种工程化免疫细胞及其用途 | |
| EP4663762A2 (en) | Immune rejection-resistant engineered cell | |
| US20210079111A1 (en) | Cd19-cd20 bispecific and dual passway car-t and methods for use thereof | |
| JPWO2023196996A5 (https=) | ||
| JPWO2021211948A5 (https=) |